Hudson Edge Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.42M | Sell |
138,879
-29,888
| -18% | -$1.74M | 1.23% | 12 |
|
|
2025
Q4 | $9.1M | Buy |
168,767
+23,799
| +16% | +$1.14M | 1.35% | 9 |
|
|
2025
Q3 | $6.54M | Buy |
144,968
+13,394
| +10% | +$626K | 1.06% | 41 |
|
|
2025
Q2 | $6.09M | Buy |
131,574
+17,191
| +15% | +$844K | 1.04% | 40 |
|
|
2025
Q1 | $6.98M | Sell |
114,383
-13,804
| -11% | -$805K | 1.42% | 10 |
|
|
2024
Q4 | $7.25M | Sell |
128,187
-9,511
| -7% | -$531K | 1.34% | 10 |
|
|
2024
Q3 | $7.12M | Buy |
137,698
+6,676
| +5% | +$313K | 1.32% | 8 |
|
|
2024
Q2 | $5.44M | Buy |
131,022
+6,757
| +5% | +$302K | 1.05% | 36 |
|
|
2024
Q1 | $6.74M | Buy |
124,265
+8,469
| +7% | +$431K | 1.32% | 12 |
|
|
2023
Q4 | $5.94M | Buy |
115,796
+15,983
| +16% | +$839K | 1.38% | 18 |
|
|
2023
Q3 | $5.79M | Buy |
99,813
+8,229
| +9% | +$504K | 1.89% | 10 |
|
|
2023
Q2 | $5.86M | Buy |
91,584
+3,322
| +4% | +$223K | 1.86% | 17 |
|
|
2023
Q1 | $6.12M | Buy |
88,262
+15,120
| +21% | +$1.07M | 1.9% | 8 |
|
|
2022
Q4 | $5.26M | Buy |
73,142
+340
| +0.5% | +$25.6K | 1.8% | 7 |
|
|
2022
Q3 | $5.17M | Sell |
72,802
-7,674
| -10% | -$557K | 1.93% | 7 |
|
|
2022
Q2 | $6.2M | Sell |
80,476
-11,447
| -12% | -$872K | 2.26% | 3 |
|
|
2022
Q1 | $6.71M | Sell |
91,923
-13,245
| -13% | -$889K | 2.11% | 5 |
|
|
2021
Q4 | $6.56M | Buy |
105,168
+11,714
| +13% | +$687K | 2.03% | 4 |
|
|
2021
Q3 | $5.53M | Buy |
93,454
+6,464
| +7% | +$426K | 1.82% | 6 |
|
|
2021
Q2 | $5.81M | Buy |
86,990
+4,192
| +5% | +$273K | 1.85% | 5 |
|
|
2021
Q1 | $5.23M | Buy |
82,798
+5,275
| +7% | +$328K | 1.73% | 12 |
|
|
2020
Q4 | $4.81M | Buy |
77,523
+5,642
| +8% | +$347K | 1.71% | 14 |
|
|
2020
Q3 | $4.33M | Sell |
71,881
-26,353
| -27% | -$1.59M | 1.74% | 8 |
|
|
2020
Q2 | $5.78M | Sell |
98,234
-24,875
| -20% | -$1.49M | 1.86% | 12 |
|
|
2020
Q1 | $6.86M | Sell |
123,109
-1,449
| -1% | -$88.6K | 2.61% | 2 |
|
|
2019
Q4 | $8M | Sell |
124,558
-21,951
| -15% | -$1.26M | 2.1% | 3 |
|
|
2019
Q3 | $7.43M | Sell |
146,509
-500
| -0.3% | -$23.5K | 2.09% | 5 |
|
|
2019
Q2 | $6.67M | Buy |
147,009
+8,058
| +6% | +$375K | 1.94% | 10 |
|
|
2019
Q1 | $6.63M | Sell |
138,951
-7,641
| -5% | -$381K | 2% | 13 |
|
|
2018
Q4 | $7.62M | Sell |
146,592
-61,840
| -30% | -$3.32M | 2.36% | 3 |
|
|
2018
Q3 | $12.9M | Sell |
208,432
-16,579
| -7% | -$984K | 2.3% | 4 |
|
|
2018
Q2 | $12.5M | Buy |
225,011
+148
| +0.1% | +$7.99K | 2.32% | 3 |
|
|
2018
Q1 | $14.2M | Sell |
224,863
-33,054
| -13% | -$2.13M | 2.15% | 10 |
|
|
2017
Q4 | $15.8M | Sell |
257,917
-7,324
| -3% | -$458K | 2.18% | 8 |
|
|
2017
Q3 | $16.9M | Sell |
265,241
-54,074
| -17% | -$3.16M | 2.4% | 2 |
|
|
2017
Q2 | $17.8M | Buy |
319,315
+10,490
| +3% | +$571K | 2.5% | 6 |
|
|
2017
Q1 | $16.8M | Buy |
308,825
+53,221
| +21% | +$2.92M | 2.24% | 7 |
|
|
2016
Q4 | $14.9M | Buy |
255,604
+27,444
| +12% | +$1.5M | 2.04% | 19 |
|
|
2016
Q3 | $12.3M | Buy |
228,160
+215,865
| +1,756% | +$13.9M | 1.84% | 29 |
|
|
2016
Q2 | $904K | Sell |
12,295
-105
| -0.8% | -$7.42K | 0.13% | 56 |
|
|
2016
Q1 | $792K | Sell |
12,400
-100
| -0.8% | -$6.31K | 0.08% | 107 |
|
|
2015
Q4 | $860K | Hold |
12,500
| – | – | 0.08% | 104 |
|
|
2015
Q3 | $740K | Buy |
12,500
+700
| +6% | +$44.4K | 0.04% | 106 |
|
|
2015
Q2 | $785K | Sell |
11,800
-1,060
| -8% | -$69.9K | 0.03% | 107 |
|
|
2015
Q1 | $829K | Sell |
12,860
-200
| -2% | -$12.5K | 0.03% | 107 |
|
|
2014
Q4 | $771K | Hold |
13,060
| – | – | 0.03% | 105 |
|
|
2014
Q3 | $668K | Hold |
13,060
| – | – | 0.02% | 105 |
|
|
2014
Q2 | $634K | Buy |
13,060
+10
| +0.1% | +$493 | 0.02% | 105 |
|
|
2014
Q1 | $678K | Hold |
13,050
| – | – | 0.03% | 103 |
|
|
2013
Q4 | $694K | Sell |
13,050
-150
| -1% | -$7.64K | 0.03% | 103 |
|
|
2013
Q3 | $611K | Sell |
13,200
-250
| -2% | -$11K | 0.03% | 103 |
|
|
2013
Q2 | $601K | Buy |
+13,450
| New | +$584K | 0.02% | 105 |
|
Other funds holding BMY
VCM
VPM
Hudson Edge Investment Partners's BMY Position: Q1 2026 in Review
Hudson Edge Investment Partners reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, selling an estimated $1.74M and leaving 138,879 shares worth $8.42M. The position accounts for 1.23% of the portfolio, ranked #12.
Hudson Edge Investment Partners first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.8M in Q2 2017. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Hudson Edge Investment Partners held 138,879 shares of Bristol-Myers Squibb worth $8.42M as of Q1 2026.
- Hudson Edge Investment Partners sold 29,888 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.74M.
- Bristol-Myers Squibb made up 1.23% of Hudson Edge Investment Partners's portfolio in Q1 2026, its #12 holding.
- Hudson Edge Investment Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Hudson Edge Investment Partners's Bristol-Myers Squibb position peaked at $17.8M in Q2 2017.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Hudson Edge Investment Partners's 13F filing for Q1 2026, filed 27 Apr 2026.